Marburg vaccine: Walter Reed Army Institute of Research begins phase 1 clinical trial

The Walter Reed Army Institute of Research (WRAIR) this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers. The WRAIR study evaluates the VRC-MARADC087-00-VP vaccine, developed by the Vaccine Research Center (VRC) of the National Institute of Allergy ["]

The post Marburg vaccine: Walter Reed Army Institute of Research begins phase 1 clinical trial appeared first on Outbreak News Today.